GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Long-Term Debt

Aroa Biosurgery (ASX:ARX) Long-Term Debt : A$0.00 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Long-Term Debt?

Aroa Biosurgery's Long-Term Debt for the quarter that ended in Mar. 2024 was A$0.00 Mil.

Aroa Biosurgery's quarterly Long-Term Debt increased from Mar. 2023 (A$0.00 Mil) to Sep. 2023 (A$5.50 Mil) but then declined from Sep. 2023 (A$5.50 Mil) to Mar. 2024 (A$0.00 Mil).


Aroa Biosurgery Long-Term Debt Historical Data

The historical data trend for Aroa Biosurgery's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Long-Term Debt Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
11.57 - - - -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Long-Term Debt Get a 7-Day Free Trial - 4.41 - 5.50 -

Aroa Biosurgery  (ASX:ARX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Aroa Biosurgery Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines